The impact of hypoalbuminemia and its correlation with D-dimer and IL-6 on severity and 14-day mortality in COVID-19 patients | [Anaesthesia, Pain and Intensive Care • 2023]

Author(s):

1. Arie Utariani: Department of Anaesthesiology and Reanimation, DR Soetomo Medical Hospital,East Java, Indonesia.

2. Hamzah Hamzah: Department of Anaesthesiology and Reanimation, DRSoetomo Medical Hospital,East Java, Indonesia.

3. Bambang Pujo Semedi: Department of Anaesthesiology and Reanimation, DRSoetomo Medical Hospital,East Java, Indonesia.

4. Markus Gatot Sura Wijaya: Department of Anaesthesiology and Reanimation, DRSoetomo Medical Hospital,East Java,Indonesia

Abstract:

Background & Objective: COVID-19 took the world by storm, but it also allowed the healthcare professionals to conduct big studies regarding various molecular and biochemical changes produced by the disease. We analyzed the impact of hypoalbuminemia on the severity and 14-day mortality in COVID-19 patients. Methodology: It was an analytical observational, prospective cohort study design. Clinical and laboratory data collection was carried out in the COVID-19 isolation room of Dr. Soetomo Hospital, between July and October 2020. Serum albumin, D-dimer, and interleukin 6 (IL-6) levels were measured on the day of admission. Statistical analysis using Kolmogorov-Smirnov, Mann-Whitney test, regression test, ROC curve, and 14-day risk of mortality were tested using Univariate Cox Regression and Multivariate Cox Regression tests. The Kaplan Meier test was used to analyze life expectancy. Results: Of the 119 study subjects, 71 (59.7%) were categorized as severe, and 48 (40.3%) as not severe. Out of the total, 36 (30.25%) patients expired within 14 days of admission, and 83 (69.75%) survived. Regression analysis showed the effect of age on albumin (P < 0.001), albumin on D-dimer (P = 0.003), albumin on disease severity (P < 0.001), and albumin on 14-day mortality (P < 0.001). Albumin was not significantly associated with IL-6 (P = 0.126). The value of albumin as a predictor of severity was 3.28 g/dL, with a sensitivity of 74.6% and a specificity of 77.1%. Conclusion: The state of hypoalbuminemia affects the disease severity and mortality of COVID-19; albumin is significantly associated with D-dimer. Poor prognosis is expected if the albumin value < 3.28 in geriatric and obese patients with a high 14-days mortality. Abbreviations: CRP - C-reactive protein; IL-6 - Interleukin 6; PCR - Polymerase Chain Reaction; PPV+ - Positive Predictive Value; NPV- - Negative Prediction Value; ROC - Receiver Operating Characteristic test; TNF - Tumor Necrosis Factor

Page(s): 440-450

DOI: 10.35975/apic.v27i5.1795

Published: Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 5, Year: 2023

Keywords:

COVID19 , Mortality , Hypoalbuminemia , Albumin , IL6 , Severity , Ddimer , Covid19

References:

[1] Liu J,Liao X,Qian S,Yuan J,Wang F,Liu Y,Shenzhen Y .2020 .. Emerg Infect Dis, 26(6) : 1320-1323.

[2] Holshue ML,DeBolt C,Lindquist S,Lofy KH,Wiesman J,Bruce H . .. 2020 Mar, 5(10) : 929-936.

[3] Gorham J,Moreau A,Corazza F,Peluso L,Ponthieux F,Talamonti M . .Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis. 2020 Dec, 15(12) : e0244628.

[4] Peiris JS,Guan Y,Yuen KY . .Severe acute respiratory syndrome. Nat Med, 10(12 Suppl)) : S88-97.

[5] Matthay MA,Aldrich JM,Gotts JE . .Treatment for severe acute respiratory distress syndrome from. COVID-19. Lancet Respir Med, 2600(20) : 30127-2.

[6] Chen C,Zhou Y,Wang DW . .SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz, 45(3) : 230-232.

[7] Moman RN,Gupta N,Varacallo M.,Physiology M.,Island (FL): StatPearls Publishing M. .2023 .Dec 26. , : .

[8] Fasano M,Curry S,Terreno E,Galliano M,Fanali G,Narciso P .2005 .The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12) : 787-96.

[9] .2007 .Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol (Tokyo), 53(1) : 37-42.

[10] Yin M,Si L,Qin W,Li C,Zhang J,Yang H . .Predictive Value of Serum Albumin Level for the Prognosis of Severe Sepsis Without Exogenous Human Albumin Administration: A Prospective Cohort Study. J Intensive Care Med, 33(12) : 687-694.

[11] Abdeen Y,Kaako A,Ahmad Amin Z,Muhanna A,Josefine Froessl L,Alnabulsi M .2021 .. 2021 Jun, 9 : 9963274.

[12] Zhang Y,Zheng L,Liu L,Zhao M,Xiao J,Zhao Q .2020 .Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city. China. Liver Int, 40(9) : 2095-2103.

[13] Qin C,Zhou L,Hu Z,Zhang S,Yang S,Tao Y . .Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19. 2020 Jul, 71(15) : 762-768.

[14] Soeters PB,Wolfe RR,Shenkin A,Significance. JPEN J Parenter Enteral Nutr Clinical . .. , 43(2) : 181-193.

[15] Ramadori G. .2020 .Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients. Hepatoma Res, 10 : 2394-5079.

[16] Utariani A,Rahardjo E,Perdanakusuma DS .2020 .Effects of Albumin Infusion on Serum Levels of Albumin, Proinflammatory Cytokines (TNF-α, IL-1, and IL-6), CRP, and MMP-8; Tissue Expression of EGRF, ERK1, ERK2, TGF-β, Collagen, and MMP8; and Wound Healing in Sprague Dawley Rats. Int J Inflam. 2020 May, 20 : 3254017.

[17] Violi F,Ceccarelli G,Cangemi R,Alessandri F,D'Ettorre G,Oliva A . .. 2020 Jul, 17(3) : 400-401.

[18] Aloisio E,Serafini L,Chibireva M,Dolci A,Panteghini M. Hypoalbuminemia . .and elevated D-dimer in COVID-19 patients: a call for result harmonization. -1038, 58(11) : e255-e256.

[19] Violi F,Ceccarelli G,Loffredo L,Alessandri F,Cipollone F,D'ardes D F .2021 .. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost, 121(1) : 1721486-105.

[20] Xu Y,Yang H,Wang J,Li X,Xue C,Niu C . .Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China. 2021 Jun, 24 : 2785-2797.

[21] Gradel KO,Thomsen RW,Lundbye-Christensen S,Nielsen H,Schønheyder HC .2010 .Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a populationbased cohort study. Clin Microbiol Infect, 03284(4) : 0691-32.

[22] Sproston NR,Ashworth JJ .2018 .Role of C-Reactive Protein at Sites of Inflammation and Infection. 2018 Apr, 13 : 754.

[23] Juvela J,Kuhmonen S,Siironen J,J. J .2012 .C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien), 154(3) : 397-404.

[24] Ho KM,Lee KY,Dobb GJ,Webb SA . .C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med, 34(3) : 481-7.

[25] Liu F,Li L,Xu M,Wu J,Luo D,Zhu Y,Virol Clin .2020 .Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. , 127 : 104370.

[26] -nCoV-clinical- . .Living guidance for clinical management of COVID-19; 2021. , : .

[27] Kheir M,Saleem F,Wang C,Mann A,Chua J . .Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. 2021 Mar, 16(3) : e0248358.

[28] Chen C,Zhang Y,Zhao X,Tao M,Yan W,Fu Y. Hypoalbuminemia - . .An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis. 2021 Sep, 9 : 3699-3710.

[29] Shorr AF,Thomas SJ,Alkins SA,Fitzpatrick TM,Ling GS . .Ddimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest, 121(4) : 1262-8.

[30] Nugroho J,Wardhana A,Maghfirah I,Mulia EPB,Rachmi DA,A'yun MQ .2021 .Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis. Int J Lab Hematol, 43(1) : 110-115.

[31] Vidali S,Morosetti D,Cossu E,Luisi MLE,Pancani S,Semeraro V .2020 .D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res, 6(2) : 00260-2020.

[32] Poudel A,Poudel Y,Adhikari A,Aryal BB,Dangol D,Bajracharya T .2021 .D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. , 16(8) : e0256744.

[33] Vatansever HS,Becer E .2020 .Relationship between IL-6 and COVID-19: to be considered during treatment. Future Virol, 0168 : 0168.

Citations

Downloads

Views